RevenueNet IncomeP/EP/SEBITDividendStocksMarket capitalizationDebtLiabilitiesEquityAAQSEmployeesROEROAROCE
Chongqing Lummy Pharmaceutical Co Stock

Chongqing Lummy Pharmaceutical Co ROCE 2024

Chongqing Lummy Pharmaceutical Co ROCE

0.03

Ticker

300006.SZ

ISIN

CNE100000H10

In 2024, Chongqing Lummy Pharmaceutical Co's return on capital employed (ROCE) was 0.03, a -159.78% increase from the -0.05 ROCE in the previous year.

Chongqing Lummy Pharmaceutical Co Aktienanalyse

What does Chongqing Lummy Pharmaceutical Co do?

Chongqing Lummy Pharmaceutical Co Ltd is a leading company in the pharmaceutical products sector. The company was founded in 2001 and is headquartered in Chongqing, China. Its business model focuses on the manufacturing and distribution of pharmaceutical products and medications, including those for the treatment of severe and chronic diseases. Since its establishment, the company has undergone significant development. Through the establishment of research and development departments, the company has been able to develop and manufacture innovative products. This has enabled the company to establish itself as an important player in the market. Chongqing Lummy Pharmaceutical's main products include medications for the treatment of diabetes, cancer, cardiovascular diseases, and mental disorders. The divisions of Chongqing Lummy Pharmaceutical cover various areas of pharmaceutical manufacturing, including the production of tablets, capsules, injection fluids, and ointments. There is also a department specializing in the production of raw materials and active ingredients. This allows Chongqing Lummy Pharmaceutical to control its own value chain and ensure the quality of its products. The company's most well-known products include the insulin injection fluids "Liupanshui," which have been very successful in the Chinese market. The medications "Qiliqiang" and "Jiaonang" for the treatment of breast cancer and the severe acute respiratory syndrome SARS-CoV-2 have also been very successful. The company also has a strong presence in other Asian countries, such as India and Vietnam. Chongqing Lummy Pharmaceutical focuses on quality and innovation. The company holds several certifications and has established a quality assurance system to ensure that all products meet the highest standards. Additionally, the company invests heavily in research and development to bring innovative products to the market. Chongqing Lummy Pharmaceutical also participates in research projects with other companies and institutions to promote collaboration in the pharmaceutical industry. In recent years, the company has achieved strong growth. It has a wide portfolio of products and a strong presence in Asia. In the future, the company plans to further expand its market position and broaden its product range. Chongqing Lummy Pharmaceutical has good chances of establishing itself as a major player in the global market for pharmaceutical products. Chongqing Lummy Pharmaceutical Co ist eines der beliebtesten Unternehmen auf Eulerpool.com.

ROCE Details

Unraveling Chongqing Lummy Pharmaceutical Co's Return on Capital Employed (ROCE)

Chongqing Lummy Pharmaceutical Co's Return on Capital Employed (ROCE) is a financial metric that measures the company's profitability and efficiency with respect to the capital employed. It is calculated by dividing earnings before interest and tax (EBIT) by the employed capital. A higher ROCE indicates that the company is effectively utilizing its capital to generate profits.

Year-to-Year Comparison

Analyzing Chongqing Lummy Pharmaceutical Co's ROCE annually provides valuable insights into its efficiency in using its capital to generate profits. An increasing ROCE indicates improved profitability and operational efficiency, whereas a decrease might signal potential issues in capital utilization or business operations.

Impact on Investments

Chongqing Lummy Pharmaceutical Co's ROCE is a critical factor for investors and analysts for evaluating the company’s efficiency and profitability. A higher ROCE can make the company an attractive investment, as it often signifies that the firm is generating adequate profits from its employed capital.

Interpreting ROCE Fluctuations

Changes in Chongqing Lummy Pharmaceutical Co’s ROCE are attributed to variations in EBIT or the capital employed. These fluctuations offer insights into the company’s operational efficiency, financial performance, and strategic financial management, assisting investors in making informed investment decisions.

Frequently Asked Questions about Chongqing Lummy Pharmaceutical Co stock

What is the ROCE (Return on Capital Employed) of Chongqing Lummy Pharmaceutical Co this year?

The ROCE of Chongqing Lummy Pharmaceutical Co is 0.03 undefined this year.

How has the ROCE (Return on Capital Employed) of Chongqing Lummy Pharmaceutical Co developed compared to the previous year?

The ROCE of Chongqing Lummy Pharmaceutical Co has increased by -159.78% decreased compared to the previous year.

What does a high ROCE (Return on Capital Employed) mean for investors of Chongqing Lummy Pharmaceutical Co?

A high Return on Capital Employed (ROCE) indicates that Chongqing Lummy Pharmaceutical Co has efficient capital utilization and is able to achieve a higher return on its invested capital. This can be appealing to investors.

What does a low ROCE (Return on Capital Employed) mean for investors of Chongqing Lummy Pharmaceutical Co?

A low ROCE (Return on Capital Employed) can indicate that Chongqing Lummy Pharmaceutical Co has an inefficient utilization of its capital and may have difficulty in achieving a satisfactory return on its invested capital. This can be uncertain or unattractive for investors.

How does an increase in ROCE from Chongqing Lummy Pharmaceutical Co impact the company?

An increase in the ROCE of Chongqing Lummy Pharmaceutical Co can be an indicator of improved company efficiency and show that it is achieving higher profits in relation to its investments.

How does a reduction in the ROCE of Chongqing Lummy Pharmaceutical Co affect the company?

A decrease in ROCE of Chongqing Lummy Pharmaceutical Co can be an indicator of deteriorated efficiency of the company, indicating that it is generating lower profits in relation to its investments.

What are some factors that can influence the ROCE of Chongqing Lummy Pharmaceutical Co?

Some factors that can affect Chongqing Lummy Pharmaceutical Co's ROCE include efficiency in managing assets, profitability of investments, cost efficiency, and market conditions.

Why is the ROCE of Chongqing Lummy Pharmaceutical Co so important for investors?

The ROCE of Chongqing Lummy Pharmaceutical Co is important for investors as it is an indicator of the company's efficiency and shows how successful the company is in relation to its investments. A high ROCE can indicate strong financial performance of the company.

What strategic measures can Chongqing Lummy Pharmaceutical Co take to improve the ROCE?

To improve the ROCE, Chongqing Lummy Pharmaceutical Co can take measures such as increasing efficiency in asset management, optimizing investments, cost savings, and exploring new revenue sources. It is important for the company to conduct a thorough review of its operations to determine the best strategic actions to improve the ROCE.

How much dividend does Chongqing Lummy Pharmaceutical Co pay?

Over the past 12 months, Chongqing Lummy Pharmaceutical Co paid a dividend of 0.05 CNY . This corresponds to a dividend yield of about 1.03 %. For the coming 12 months, Chongqing Lummy Pharmaceutical Co is expected to pay a dividend of 0 CNY.

What is the dividend yield of Chongqing Lummy Pharmaceutical Co?

The current dividend yield of Chongqing Lummy Pharmaceutical Co is 1.03 %.

When does Chongqing Lummy Pharmaceutical Co pay dividends?

Chongqing Lummy Pharmaceutical Co pays a quarterly dividend. This is distributed in the months of August, September, August, August.

How secure is the dividend of Chongqing Lummy Pharmaceutical Co?

Chongqing Lummy Pharmaceutical Co paid dividends every year for the past 0 years.

What is the dividend of Chongqing Lummy Pharmaceutical Co?

For the upcoming 12 months, dividends amounting to 0 CNY are expected. This corresponds to a dividend yield of 0 %.

In which sector is Chongqing Lummy Pharmaceutical Co located?

Chongqing Lummy Pharmaceutical Co is assigned to the 'Health' sector.

Wann musste ich die Aktien von Chongqing Lummy Pharmaceutical Co kaufen, um die vorherige Dividende zu erhalten?

To receive the latest dividend of Chongqing Lummy Pharmaceutical Co from 7/3/2020 amounting to 0.05 CNY, you needed to have the stock in your portfolio before the ex-date on 7/3/2020.

When did Chongqing Lummy Pharmaceutical Co pay the last dividend?

The last dividend was paid out on 7/3/2020.

What was the dividend of Chongqing Lummy Pharmaceutical Co in the year 2023?

In the year 2023, Chongqing Lummy Pharmaceutical Co distributed 0 CNY as dividends.

In which currency does Chongqing Lummy Pharmaceutical Co pay out the dividend?

The dividends of Chongqing Lummy Pharmaceutical Co are distributed in CNY.

Stock savings plans offer an attractive way for investors to build wealth over the long term. One of the main advantages is the so-called cost-average effect: by regularly investing a fixed amount in stocks or stock funds, you automatically buy more shares when prices are low, and fewer when they are high. This can lead to a more favorable average price per share over time. In addition, stock savings plans allow small investors access to expensive stocks, as they can participate with small amounts. Regular investment also promotes a disciplined investment strategy and helps to avoid emotional decisions, such as impulsive buying or selling. Furthermore, investors benefit from the potential appreciation of the stocks as well as from dividend distributions, which can be reinvested, enhancing the compounding effect and thus the growth of the invested capital.

Andere Kennzahlen von Chongqing Lummy Pharmaceutical Co

Our stock analysis for Chongqing Lummy Pharmaceutical Co Revenue stock includes important financial indicators such as revenue, profit, P/E ratio, P/S ratio, EBIT, as well as information on dividends. We also assess aspects such as stocks, market capitalization, debt, equity, and liabilities of Chongqing Lummy Pharmaceutical Co Revenue. If you are looking for more detailed information on these topics, we offer comprehensive analyses on our subpages.